EUCTR2005-003770-23-SI进行中（未招募）不适用
Randomized, two arm, controlled study to compare the efficacy oforal ibandronate treatment versus intravenous zoledronate in patientswith symptomatic Multiple Myeloma
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 424
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with multiple myeloma & confirmation of bone lesions
- •Age > 18 years
- •Patient’s written informed consent
- •WHO performance status 0-2
- •Life expectancy of ? 6 months
- •Adequate renal function (defined by a creatinine clearance >60 ml/min)
- •No history of brain metastases
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Any circumstance liable to compromise follow-up and compliance
- •Pregnant or lactating period
- •Participation in a clinical trial with any investigational drug within 4 weeks preceding the first dose of the study drug
- •History of other concomitant cancer in evolution
- •Prior bisphosphonate treatment with the exception of bisphosphonate treatment for hypercalcemia and osteoporosis
- •Pre-scheduled radiotherapy that would fall within the study period
研究者
相似试验
进行中（未招募）
1 期
Randomized, two arm, controlled study to compare the efficacy oforal ibandronate treatment versus intravenous zoledronate in patientswith symptomatic Multiple MyelomaMultiple MyelomaEUCTR2005-003770-23-GBF. Hoffmann-La Roche Ltd424
进行中（未招募）
不适用
Randomized, two arm, controlled study to compare the efficacy oforal ibandronate treatment versus intravenous zoledronate in patientswith symptomatic Multiple MyelomaMultiple MyelomaEUCTR2005-003770-23-EEF. Hoffmann-La Roche Ltd424
进行中（未招募）
1 期
Randomized, two arm, controlled study to compare the efficacy oforal ibandronate treatment versus intravenous zoledronate in patientswith symptomatic Multiple MyelomaMultiple MyelomaEUCTR2005-003770-23-SKF. Hoffmann-La Roche Ltd424
进行中（未招募）
不适用
Randomized, two arm, controlled study to compare the efficacy oforal ibandronate treatment versus intravenous zoledronate in patientswith symptomatic Multiple MyelomaMultiple MyelomaEUCTR2005-003770-23-BEF. Hoffmann-La Roche Ltd424
进行中（未招募）
不适用
Randomized, two arm, controlled study to compare the efficacy oforal ibandronate treatment versus intravenous zoledronate in patientswith symptomatic Multiple MyelomaMultiple MyelomaEUCTR2005-003770-23-HUF. Hoffmann-La Roche Ltd424